In chronic myeloid leukemia (CML), the expression and phosphorylation level of eIF4E are up-regulated, and the activity of eIF4E in patients with advanced CML is significantly increased. This evidence concerns the gene EIF4E and chronic myelogenous leukemia, BCR-ABL1 positive.